NCT02968823

Brief Summary

Our primary aim is to determine whether licorice gargling provides meaningful analgesia after oral surgery. Specifically, we propose to test the primary hypothesis that gargling with licorice solution reduces pain after oral surgery more than gargling with sugar water. Because effective analgesia can reduce pain and/or opioid consumption, we will jointly evaluate verbal response pain scores and overall morphine consumption considering licorice to be beneficial only if it proves non-inferior on both measures and superior on at least one.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 21, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

September 5, 2023

Status Verified

August 1, 2023

Enrollment Period

5.3 years

First QC Date

November 14, 2016

Last Update Submit

August 30, 2023

Conditions

Keywords

Postoperative PainAnesthesiaOral Surgery

Outcome Measures

Primary Outcomes (1)

  • joint - pain scores and opiate consumption in Post Anesthesia Care Unit (PACU)

    A joint outcome of average pain score and total opioid consumption between the end of surgery and the first two postoperative hours. Joint hypothesis testing will be used, meaning that Licorice gargling will be deemed better than sugar-water only if found noninferior on both opioid consumption and pain score and superior on at least one of the two.

    first 2 postoperative hours

Secondary Outcomes (3)

  • joint - pain scores and opiate consumption on day of surgery

    from end of surgery until the morning of Post-Operative Day (POD) 1

  • joint - pain scores and analgesic consumption

    from surgery conclusion to Post-Operative Day (POD) 3

  • postoperative coughing

    first 2 postoperative hours

Study Arms (2)

Licorice

ACTIVE COMPARATOR

Licorice gargle

Other: Licorice

Sugar water

PLACEBO COMPARATOR

Sugar gargle

Other: Sugar water

Interventions

ExtractumLiquiritiaeFluidum, 1 g diluted in 30cc water, gargle the solution for 60 seconds without swallowing it starting preoperatively, 3 times a day until post-operative day 3

Also known as: Extractum Liquiritiae Fluidum
Licorice

Sugar gargle: Sirupus Simplex (sugar 5 g) diluted in 30cc water, gargle the solution for 60 seconds without swallowing it starting preoperatively, 3 times a day until post-operative day 3

Sugar water

Eligibility Criteria

Age12 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Oropharyngeal surgeries including:Panendoscopic surgery; elective tonsillectomy/adenotonsillectomy; demarcation and biopsy of suspected tongue carcinoma
  • Anticipated extubation in the operating room
  • American Society of Anesthesia physical status 1-3

You may not qualify if:

  • Rapid Sequence Induction
  • Known or suspected allergy to licorice or its ingredients
  • Liver failure with bleeding disorders
  • Insulin-dependent diabetes mellitus
  • Use of non-steroidal anti-inflammatory drug medication within 24 hours before surgery
  • Chronic opioid use
  • Dementia or inability to use an iv Patient-Controlled-Analgesia (PCA) pump
  • superinfected oropharyngeal tumors
  • Planned postoperative mechanical ventilation or admission to Intensive Care Unit (ICU)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MUVienna

Vienna, Austria

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Glycyrrhiza glabra extract

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Olga Plattner, M.D.

    Medical University of Vienna

    STUDY CHAIR
  • Marita Windpassinger, M.D.

    Medical University Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ao. Univ. Prof., Head of ophthalmologic anesthesia

Study Record Dates

First Submitted

November 14, 2016

First Posted

November 21, 2016

Study Start

July 1, 2017

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

September 5, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations